USP44

protein-coding

ubiquitin specific peptidase 44, the group of Ubiquitin specific peptidases

Gene summary

The protein encoded by this gene is a protease that functions as a deubiquitinating enzyme. The encoded protein is thought to help regulate the spindle assembly checkpoint by preventing early anaphase onset. This protein specifically deubiquitinates CDC20, which stabilizes the anaphase promoting complex/cyclosome. [provided by RefSeq, Dec 2016]

MANE transcript

NM_032147.5

Inheritance

AD

ClinVar variants

U:86B:13

Top phenotype

USP44-related disorder

gnomAD constraint

pLI —, LoF o/e 0.77

Max pathogenic AF

—

Genomic locus

chr12:95,516,560-95,551,476

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~34.9 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

congenital heart diseaseLIMITED

Inheritance Pattern: AD

Disease ID:MONDO:0005453

Submitter: ClinGen

USP44 was first reported in relation to autosomal dominant congenital heart disease in 2020 (Edwards et al., PMID: 32368696). 4 variants (missense, nonsense, frameshift) that have been reported in 4 probands in 2 publications (PMIDs: 32368696, 33084842) are included in this curation. The mechanism of pathogenicity appears to be loss-of-function. This gene-disease relationship is also supported by experimental evidence (NCBI fetal expression-level data, fish embryo model). Expression-level data from NCBI shows solid expression in the heart at 10 weeks gestation. Gene-editing of USP44 in fish embryos resulted in abnormal heart morphology and looping defects. In summary, there is limited evidence to support this gene-disease relationship. Although more evidence is needed to support a causal role, no convincing evidence has emerged that contradicts the gene-disease relationship. This classification was approved by the ClinGen Congenital Heart Disease GCEP on the meeting date 10/15/24 (SOP Version 11).

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to USP44 variants in ClinVar

4 Conditions Cataloged
not specifiedTotal: 86
not providedTotal: 6
USP44-related disorderTotal: 6
Moderate intellectual disabilityTotal: 1

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_032147.5. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
4
clinvar
2
clinvar
6
missense
85
clinvar
4
clinvar
3
clinvar
92
nonsense
0
start loss
0
frameshift
1
clinvar
1
splice donor/acceptor (+/-2bp)
0
Total00868599
Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 108 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_032147.5RefSeqNP_115523.25MANE Select
ENST00000258499.8EnsemblENSP00000258499.35MANE Select
NM_001042403.3RefSeqNP_001035862.15Standard
NM_001278393.2RefSeqNP_001265322.15Standard

Model Organisms & Knockout Phenotypes

Observed phenotypic effects in mouse and zebrafish models

Gene / ModelOrganismObserved Phenotype
usp44Danio rerio

Structure: pharyngeal arch cartilage

Quality: malformed

abnormal

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Post-translational protein modification
  • Metabolism of proteins
  • Ub-specific processing proteases
  • Deubiquitination

Biological Process

  • cell cycle
  • protein deubiquitination
  • proteasome-mediated ubiquitin-dependent protein catabolic process
  • cell division
  • regulation of mitotic cell cycle spindle assembly checkpoint

Molecular Function

  • thiol-dependent ubiquitin-specific protease activity
  • protein binding
  • zinc ion binding
  • thiol-dependent ubiquitinyl hydrolase activity

Cellular Component

  • nucleus
  • nucleoplasm
  • cytoplasm

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000258499
Coding exons
5
Length
34931
Individuals with no LoFs
125608
Homozygous LoFs
1
Heterozygous LoFs
139
Defined
125748
p
0.000557
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense0.6543483840.9060.00002004671
Missense (PolyPhen)101116.330.868231459
Synonymous0.7451261370.9190.000007251348
Loss of Function1.232633.70.7720.00000204382

Population LoF Frequency

PopulationCAFp-valueStatus
African0.00170.0017notable
Latino/Admixed American0.000760.00072rare
Ashkenazi Jewish0.000200.00020rare
East Asian0.000490.00049rare
Finnish0.0000500.000046rare
European (Non-Finnish)0.000580.00056rare
South Asian0.000260.00026rare
Other0.000650.00065rare

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Deubiquitinase that plays a key regulatory role in the spindle assembly checkpoint or mitotic checkpoint by preventing premature anaphase onset. Acts by specifically mediating deubiquitination of CDC20, a negative regulator of the anaphase promoting complex/cyclosome (APC/C). Deubiquitination of CDC20 leads to stabilize the MAD2L1-CDC20-APC/C ternary complex (also named mitotic checkpoint complex), thereby preventing premature activation of the APC/C. Promotes association of MAD2L1 with CDC20 and reinforces the spindle assembly checkpoint. Acts as a negative regulator of histone H2B (H2BK120ub1) ubiquitination. {ECO:0000269|PubMed:17443180, ECO:0000269|PubMed:22681888}.;

Recessive Scores

pRec
0.0872

Intolerance Scores

LoFtool
0.988
RVIS EVS
-0.29
RVIS percentile EVS
33.47

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
N
Indispensability pred.
N
Indispensability score
0.193

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.